亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

<p>Soluplus-Mediated Diosgenin Amorphous Solid Dispersion with High Solubility and High Stability: Development, Characterization and Oral Bioavailability</p>

溶解度 生物利用度 溶解 差示扫描量热法 傅里叶变换红外光谱 结晶度 化学 材料科学 无定形固体 色谱法 赋形剂 结晶 化学工程 核化学 有机化学 药理学 医学 结晶学 工程类 物理 热力学
作者
Pei Liu,Jianyu Zhou,Jinhua Chang,Liu Xigang,Hefei Xue,Ruxing Wang,Zhongsi Li,Chunshi Li,Jian Wang,Liu Cui-zhe
出处
期刊:Drug Design Development and Therapy [Dove Medical Press]
卷期号:Volume 14: 2959-2975 被引量:36
标识
DOI:10.2147/dddt.s253405
摘要

The traditional Chinese medicine, diosgenin (Dio), has attracted increasing attention because it possesses various therapeutic effects, including anti-tumor, anti-infective and anti-allergic properties. However, the commercial application of Dio is limited by its extremely low aqueous solubility and inferior bioavailability in vivo. Soluplus, a novel excipient, has great solubilization and capacity of crystallization inhibition. The purpose of this study was to prepare Soluplus-mediated Dio amorphous solid dispersions (ASDs) to improve its solubility, bioavailability and stability.The crystallization inhibition studies were firstly carried out to select excipients using a solvent shift method. According to solubility and dissolution results, the preparation methods and the ratios of drug to excipient were further optimized. The interaction between Dio and Soluplus was characterized by differential scanning calorimetry (DSC), fourier transform infrared (FT-IR) spectroscopy, scanning electron microscopy (SEM), powder X-ray diffraction (PXRD) and molecular docking. The pharmacokinetic study was conducted to explore the potential of Dio ASDs for oral administration. Furthermore, the long-term stability of Dio ASDs was also investigated.Soluplus was preliminarily selected from various excipients because of its potential to improve solubility and stability. The optimized ASDs significantly improved the aqueous solubility of Dio due to its amorphization and the molecular interactions between Dio and Soluplus, as evidenced by dissolution test in vitro, DSC, FT-IR spectroscopy, SEM, PXRD and molecular docking technique. Furthermore, pharmacokinetic studies in rats revealed that the bioavailability of Dio from ASDs was improved about 5 times. In addition, Dio ASDs were stable when stored at 40°C and 75% humidity for 6 months.These results indicated that Dio ASDs, with its high solubility, high bioavailability and high stability, would open a promising way in pharmaceutical applications.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
斯文败类应助科研通管家采纳,获得10
22秒前
39秒前
米里迷路完成签到 ,获得积分10
1分钟前
科研狗完成签到 ,获得积分10
1分钟前
朱朱子完成签到 ,获得积分10
1分钟前
jokerhoney完成签到,获得积分10
1分钟前
1分钟前
科目三应助Grayball采纳,获得10
1分钟前
哈密瓜牛奶完成签到 ,获得积分10
2分钟前
优雅的背包完成签到 ,获得积分10
2分钟前
2分钟前
2分钟前
WYF发布了新的文献求助10
2分钟前
怡然的友容完成签到 ,获得积分10
2分钟前
大胆的凡儿完成签到 ,获得积分10
3分钟前
WYF完成签到,获得积分10
3分钟前
yi完成签到 ,获得积分10
3分钟前
wrl2023完成签到,获得积分10
3分钟前
3分钟前
白白发布了新的文献求助10
3分钟前
苏苏完成签到 ,获得积分10
4分钟前
4分钟前
4分钟前
Lshyong完成签到 ,获得积分10
5分钟前
Mistletoe完成签到 ,获得积分10
5分钟前
zyjsunye完成签到 ,获得积分0
5分钟前
5分钟前
5分钟前
zhangxr发布了新的文献求助10
5分钟前
6分钟前
轮胎配方发布了新的文献求助10
6分钟前
小蘑菇应助风中的夕阳采纳,获得10
6分钟前
zhangxr完成签到,获得积分10
6分钟前
6分钟前
6分钟前
奶盐牙牙乐完成签到 ,获得积分10
7分钟前
7分钟前
L_MD完成签到,获得积分10
7分钟前
Yingkun_Xu发布了新的文献求助10
7分钟前
Yingkun_Xu完成签到,获得积分10
7分钟前
高分求助中
Evolution 10000
ISSN 2159-8274 EISSN 2159-8290 1000
Becoming: An Introduction to Jung's Concept of Individuation 600
Ore genesis in the Zambian Copperbelt with particular reference to the northern sector of the Chambishi basin 500
A new species of Coccus (Homoptera: Coccoidea) from Malawi 500
A new species of Velataspis (Hemiptera Coccoidea Diaspididae) from tea in Assam 500
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3162323
求助须知:如何正确求助?哪些是违规求助? 2813328
关于积分的说明 7899665
捐赠科研通 2472791
什么是DOI,文献DOI怎么找? 1316526
科研通“疑难数据库(出版商)”最低求助积分说明 631365
版权声明 602142